These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7939074)

  • 21. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
    Grant RW; Singer DE; Meigs JB
    Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
    Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI
    Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term patient compliance with prescribed regimens of calcium channel blockers.
    Farmer KC; Jacobs EW; Phillips CR
    Clin Ther; 1994; 16(2):316-26; discussion 271-2. PubMed ID: 8062325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
    Mallion JM; Dutrey-Dupagne C; Vaur L; Genes N; Renault M; Elkik F; Baguet P; Boutelant S
    J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring one-year compliance to antihypertension medication in the Seychelles.
    Bovet P; Burnier M; Madeleine G; Waeber B; Paccaud F
    Bull World Health Organ; 2002; 80(1):33-9. PubMed ID: 11884971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind evaluation of amlodipine in patients with chronic, stable angina: sustained efficacy and lack of "withdrawal phenomenon" upon abrupt discontinuation.
    Mehta JL; Lopez LM
    Clin Cardiol; 1994 Sep; 17(9 Suppl 3):III17-22. PubMed ID: 9156956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of nifedipine coat-core and amlodipine on systemic arterial stiffness modulated by sympathetic and parasympathetic activity in hypertensive patients.
    Fukuda M; Masuda T; Ogura MN; Moriya T; Tanaka K; Yamamoto K; Ishii A; Yonezawa R; Noda C; Izumi T
    Hypertens Res; 2009 May; 32(5):392-8. PubMed ID: 19373239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: internet-mediated open-label crossover trial of calcium channel blockers for hypertension (i-TECHO trial).
    Ryuzaki M; Nakamoto H; Nishida E; Sone M; Nakajima S; Yoshimoto M; Suzuki Y; Itagaki K
    J Hypertens; 2007 Nov; 25(11):2352-8. PubMed ID: 17921832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using administrative data to compare the relative effectiveness of amlodipine vs nifedipine CC.
    Lenert LA; Linde-Zwirble W; Newbold R; Korenblat BM; Doherty J; Smith ME
    Am J Manag Care; 1999 Dec; 5(12):1535-40. PubMed ID: 11066620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of amlodipine in stable effort angina. Comparison with diltiazem in terms of efficacy, tolerability and maintenance of the anti-ischemic action 24 hours after the last dose].
    Marchand X; Tibi T; Bernaud C; Morand P
    Ann Cardiol Angeiol (Paris); 1996 Feb; 45(2):74-82. PubMed ID: 8734139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
    Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S
    J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P&T Committee review of nifedipine GITS: new modality for angina and hypertension.
    Weintraub M; Horn J; Krakoff L; Vetrovec G
    Hosp Formul; 1990 Mar; 25 Suppl A():10-4. PubMed ID: 10103975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose timing and patient compliance with two antibiotic treatment regimens for lower respiratory tract infections in primary care.
    Cals JW; Hopstaken RM; Le Doux PH; Driessen GA; Nelemans PJ; Dinant GJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):531-6. PubMed ID: 18457936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treating angina and hypertension with ISTIN.
    Ir Med J; 1995; 88(3):94. PubMed ID: 7635687
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nifedipine in short supply].
    Fazekas T
    Orv Hetil; 1985 Jul; 126(28):1755. PubMed ID: 4080359
    [No Abstract]   [Full Text] [Related]  

  • 40. Dosage frequency and drug-compliance behaviour--a comparative study on compliance with a medication to be taken twice or four times daily.
    Kruse W; Eggert-Kruse W; Rampmaier J; Runnebaum B; Weber E
    Eur J Clin Pharmacol; 1991; 41(6):589-92. PubMed ID: 1815972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.